LAUREN MOORE: Open Payments
NPI 1467913095 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 52 payments from 27 companies in 2025. Trend: 2023 $516 · 2024 $736 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $345 |
| ABBVIE INC. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| Celgene Corporation | 3 | $78 |
| Janssen Biotech, Inc. | 3 | $68 |
| GENZYME CORPORATION | 2 | $53 |
| Exelixis Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| PharmaEssentia USA Corporation | 2 | $46 |
| Geron Corporation | 2 | $42 |
Products named: KISQALI, REBLOZYL, SCEMBLIX, WAYRILZ, CABOMETYX, BESREMI, RYTELO, TAGRISSO.
Industry payments across TN — which companies pay providers there.
